P04-23. HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specific

por Wieczorek, L, Brown, BK, Wesberry, M, Ochsenbauer-Jambor, C, Kappes, JC, Lora, N, Gillis, A, Nzodom, C, Molnar, S, Michael, NL, Montefiori, D, Polonis, VR
Publicado 2009

Antigenicity and immunogenicity of a novel, acute HIV-1 Tanzanian subtype C gp145 envelope protein for clinical development

por Polonis, V, Wieczorek, L, Kalyanaraman, V, Matyas, G, Whitney, S, Williams, C, Tovanabutra, S, Sanders-Buell, E, Wesberry, M, Ochsenbauer, C, Chenine, A, Rao, M, Tong, T, Alving, C, Cheng, H, Zolla-Pazner, S, Michael, N, VanCott, T, Marovich, M
Publicado 2012